Fate Therapeutics Reports Fourth Quarter and Full Year 2013 Financial Results

Go back to Fate Therapeutics Reports Fourth Quarter and Full Year 2013 Financial Results
FATE THERAPEUTICS (NASDAQ: FATE) Delayed: 2.53 +0.01 (0.40%)
Previous Close $2.52    52 Week High $4.76 
Open $2.59    52 Week Low $1.46 
Day High $2.61    P/E N/A 
Day Low $2.48    EPS $-1.91 
Volume 4,186,793